Key indices were trading with small losses in early trade as trading resumed after a local holiday. At 9:25 IST, the barometer index, the S&P BSE Sensex, was down 29.30 points or 0.07% at 40,054.24. The Nifty 50 index was down 19.30 points or 0.16% at 12,002.35.

Investors are awaiting the Reserve Bank of India (RBI's) decision on interest rates. The RBI's Monetary Policy Committee (MPC) meeting is scheduled from 3 to 6 June 2019. The MPC of the RBI will today, 6 June 2019 announce its resolution under the Second Bi-monthly Monetary Policy Statement for 2019-20. Domestic stock market were closed yesterday, 5 June 2019, on account of Id-Ul-Fitr (Ramzan Id).

The S&P BSE Mid-Cap index was down 0.37%. The S&P BSE Small-Cap index was down 0.26%. Both these indices outperformed the Sensex.

The market breadth, indicating the overall health of the market, was strong. On the BSE, 908 shares rose and 506 shares fell. A total of 83 shares were unchanged.

Overseas, Asian shares were trading mixed Thursday as investors feared a looming US trade war with Mexico would further depress global growth.

Wall Street's major indexes rose on Wednesday as investors bet on a Federal Reserve interest rate cut after weak private sector jobs data and hopes grew that the United States and Mexico would reach an agreement to avoid US tariffs on Mexican goods.

Back home, Tata Motors rose 0.49%. Jaguar Land Rover (JLR) and BMW have announced collaboration to develop next generation electric drive systems. The collaboration seeks to advance development of electrification technology to support transition to (Autonomous, Connected, Electric, Shared) ACES.

Wipro shed 0.27%. Wipro announced that it has signed a definitive agreement to acquire International TechneGroup Incorporated (ITI), a global digital engineering and manufacturing solutions company. ITI is a world leader in Computer Aided Design (CAD) and Product Lifecycle Management (PLM) interoperability software services.

Lupin rose 0.36%. Lupin announced completion of Good Manufacturing Practices inspection of the company's Mandideep facility (Unit 2), by the Pharmaceutical and Medical Devices Agency, Japan. The inspection was conducted between 14 to 17 May 2019.